The global hypophosphatasia treatment market is experiencing significant growth fueled by increasing awareness of the disease, advancements in therapy options, and a growing patient population. The market is driven by factors such as rising prevalence of hypophosphatasia, particularly in developed regions, coupled with a surge in research and deve